Skip to main content

Part of the book series: Current Histopathology ((CUHI,volume 21))

  • 155 Accesses

Abstract

The term ‘renal bone disease’ or ‘renal osteodystrophy’ is used to describe osseous disorders occurring in patients with renal disease21,33,43,49,53,71. Abnormalities of bone are seen mainly in patients suffering from chronic renal failure (impaired glomerular filtration rate, GFR). Variants of metabolic bone disease may also occur in patients with a normal GFR, but with renal tubular acidosis, nephrotic syndrome, renal stone diseases and oxalosis. A wide spectrum of factors influences the skeleton in renal disorders: the type of renal disease, the degree of uraemia, the severity of secondary hyperparathyroidism, changes in vitamin D metabolism, accumulation of toxic products (e.g. aluminium, fluorine, iron)11,51,68,70, the type and duration of dialysis therapy and of drugs, particularly corticosteroids5,21,25,26,37,38,50. Patients with renal disease are also subject to the same conditions that affect the skeleton in normal individuals: sex, age, activity, endocrine disturbances, ethanol intake, immobilization, diabetes mellitus5 and so forth. For example, renal complications may occur in B-cell dyscrasias due to deposition of monoclonal immunoglobulins in the kidneys34.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

References

  1. Andress D. L., Kopp J. B., Maloney N. A., Coburn J. W. and Sherrard D. J. (1987). Early deposition of aluminium in bone in diabetic patients on haemodialysis. N. Engl. J. Med., 316, 292

    Article  PubMed  CAS  Google Scholar 

  2. Andress D. L., Maloney N. A., Endres D. B. and Sherrard D. J. (1986). Aluminium-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. J. Bone Miner. Res., 1, 391

    Article  PubMed  CAS  Google Scholar 

  3. Andress D. L., Maloney N. A., Coburn J. W., Endress D. B. and Sherrard D. J. (1987). Osteomalacia and aplastic bone disease in aluminium-related osteodystrophy. J. Clin. Endocrinol. Metab., 65, 11

    Article  PubMed  CAS  Google Scholar 

  4. Andress D. L., Nebeker H. G. and Ott S. M. (1987). Bone histologic response to long-term treatment with deferoxamine for aluminium-related bone disease. Kidney Int., 31, 1344

    Article  PubMed  CAS  Google Scholar 

  5. Andress D. L., Pandian M. R., Endres D. B. and Kopp J. B. (1989). Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidism. Kidney Int., 36, 471

    Article  PubMed  CAS  Google Scholar 

  6. Asai K., Miura S., Kawahara H., Toriyama T. and Kuzuya F. (1991). A comparative study of atherosclerosis and osteopenia in elderly and young hemodialysis patients. Aging (Milano), 3, 79

    CAS  Google Scholar 

  7. Avram M. M. (1980). Lower parathyroid hormone and creatinine in diabetic uremia. Contrib. Nephrol., 20, 4

    PubMed  CAS  Google Scholar 

  8. Blumenthal N. C. and Posner A. S. (1984). In vitro model of aluminium-induced osteomalacia: inhibition of hydroxyapatite formation and growth. Calcif. Tissue Int., 36, 439

    Article  PubMed  CAS  Google Scholar 

  9. Bone J. M., Davison A. M. and Robson J. S. (1972). The role of dialysate calcium concentration in osteoporosis in patients on hemodialysis. Lancet, 1, 1047

    Article  PubMed  CAS  Google Scholar 

  10. Bouillon R., Verberckmoes R. and DeMoor P. (1975). Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis. Kidney Int., 7, 422

    Article  PubMed  CAS  Google Scholar 

  11. Boyce B. F., Fell G. S. and Elder H. Y. (1982). Hypercalcaemic osteomalacia due to aluminium toxicity. Lancet, 2, 1009

    Article  PubMed  CAS  Google Scholar 

  12. Burnell J. M., Teubner E., Wegedal J. E. and Sherrard D. J. (1974). Bone crystal maturation in renal osteodystrophy in humans. J. Clin. Invest., 53, 52

    Article  PubMed  CAS  Google Scholar 

  13. Carroll R. N. P., Williams E. D., Aung T., Yeboah E. and Shackman R. (1973). The effects of renal transplantation on renal osteodystrophy. Proc. Europ. Dialysis Transpl. Assoc., 10, 446

    CAS  Google Scholar 

  14. Casey T., Stone W. J., DiRaimondo C. R., Brantley B. D., DiRaimondo C. V., Gorevic P. D. and Page D. L. (1986). Tumoral amyloidosis of bone of beta-2-microglobulin origin associated with long term hemodialysis: a new type of amyloid disease. Hum. Pathol., 17, 731

    Article  PubMed  CAS  Google Scholar 

  15. Cassidy M. J. D., Owen J. P. and Ellis H. A. (1985). Renal osteodystrophy and metastatic calcification on long-term continuous ambulatory peritoneal dialysis. Q. J. Med., 54, 29

    PubMed  CAS  Google Scholar 

  16. Chan Y., Furlong T. J., Cornish C. J. and Posen S. (1985). Dialysis osteodystrophy. A study involving 94 patients. Medicine, 64, 296

    Article  PubMed  CAS  Google Scholar 

  17. Charhon S. A., Berland Y F. and Olmer M. J. (1985). Effects of parathyroidectomy on bone formation and mineralisation in hemodialysed patients. Kidney Int., 27, 426

    Article  PubMed  CAS  Google Scholar 

  18. Charhon S. A., Chavassieux P. and Boivin G. (1987). Desferrioxamine-induced bone changes in haemodialysis patients: a histomorphometric study. Clin. Sci., 73, 227

    PubMed  CAS  Google Scholar 

  19. Charhon S. A., Chavassieux P. M., Chapuy M. C., Boivin G. Y. and Meunier P. J. (1985). Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminium intoxication. J. Lab. Clin. Med., 106, 123

    PubMed  CAS  Google Scholar 

  20. Charhon S. A., Delmas P. D. and Malaval L. (1986). Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry. J. Clin. Endocrinol. Metab., 63, 892

    Article  PubMed  CAS  Google Scholar 

  21. Coburn J. W. and Slatopolsky E. (1991). The renal osteodystrophies. Brenner B. M. and Rector F. C., The Kidney, 4th edn (p. 2057). Philadelphia: Saunders

    Google Scholar 

  22. Connor M. O., Garrett P., Dockery M., Donohoe J. F., Doyle G. D., Carmody M. and Dervan P. A. (1986). Aluminium-related bone disease: correlation between symptoms, osteoid volume and aluminium staining. Amer. J. Clin. Pathol., 86, 168

    CAS  Google Scholar 

  23. Cournot-Witmer G., Plachot J. J. and Bourdeau A. (1986). Effect of aluminium on bone and cell localization. Kidney Int, 29(Suppl. 18), 37

    Google Scholar 

  24. Cournot-Witmer G., Zingraff J. and Plachot J. J. (1981). Aluminium localization in bone from haemodialyzed patients: relationship to matrix mineralisation. Kidney Int., 20, 375

    Article  PubMed  CAS  Google Scholar 

  25. Cundy T., Hamdy N., Gray R., Jackson B. and Kanis J. A. (1985). Hyperparathyroid bone disease in chronic renal failure. Ulster Med. J., 54, s34

    PubMed  Google Scholar 

  26. Cundy T., Hand D. J. and Oliver D. O. (1985). Who gets renal bone disease before beginning dialysis? Brit. Med. J., 290, 271

    Article  CAS  Google Scholar 

  27. Dalen N. and Alvestrand A. (1973). Bone mineral content in chronic renal failure and after renal transplantation. Clin. Nephrol., 1, 338

    PubMed  CAS  Google Scholar 

  28. Denton F., Freemont A. J. and Ball J. (1984). Detection and distribution of aluminium in bone. J. Clin. Pathol., 37, 136

    Article  PubMed  CAS  Google Scholar 

  29. DiRaimondo C. R., Casey T. T., DiRaimondo C. V. and Stone W. J. (1986). Pathologic fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients. Nephron, 43, 22

    Article  PubMed  CAS  Google Scholar 

  30. Editorials. (1991). Dialysis amyloidosis. Lancet, 338, 349

    Article  Google Scholar 

  31. Ellis H. A. and Peart K. M. (1973). Azotemic renal osteodystrophy, a quantitative study on iliac. J. Clin. Pathol., 26, 83

    Article  PubMed  CAS  Google Scholar 

  32. Ellis H. A., Pierides A. M., Feest T. G., Ward M. K. and Kerr D. N. S. (1977). Histopathology of renal osteodystrophy with particular reference to the effects of 1 alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis. Clin. Endocrinol, 7(Suppl.), 31

    Article  Google Scholar 

  33. Feest T. G., Ward M. K., Ellis, H. A., Conceicao S., Pierides A. M., Aird E., Simpson W., Cook D. B. and Kerr D. N. S. (1977). Renal bone disease -what is it and why does it happen? Clin. Endocrinol., 7(Suppl.), 19

    Article  CAS  Google Scholar 

  34. Gallo G. (1991). Renal complications of B-cell dyscrasias. N. Engl. J. Med., 324, 1889

    Article  PubMed  CAS  Google Scholar 

  35. Gejyo F., Yamada T. and Odani S. (1985). A new form of amyloid protein associated with chronic hemodialysis was identified as /32- microglobulin. Biochem. Biophys. Res. Commun., 129, 701

    Article  PubMed  CAS  Google Scholar 

  36. Gilmour J., Wu G., Khanna R., Schilling H., Mitwalli A. and Oreopoulos D. G. (1985). Long-term continuous ambulatory peritoneal dialysis. Peritonea/ Dial. Bull., 5, 112

    Google Scholar 

  37. Grech P., Martin T. J., Barrington N. A. and Ell P. J. (1985). Diagnosis of Metabolic Bone Disease London: Chapman & Hall

    Google Scholar 

  38. Hodgson S. F. (1986). Skeletal remodeling and renal osteodystrophy. Semin. Nephrol., 6, 42

    PubMed  CAS  Google Scholar 

  39. Hutchinson A. J., Freemont A. J., Lumb G. A. and Gokal R. (1991). Renal osteodystrophy in CAPD. Adv. Peritoneal Dial., 7, 237

    Google Scholar 

  40. Joffe P., Podenphant J. and Haef J. G. (1989). Bone histology in CAPD patients: a comparison with haemodialysis and conservatively treated chronic uremics. Adv. Peritoneal Dial., 5, 171

    CAS  Google Scholar 

  41. Kachel H. G., Altmeyer P., Baldamus C. A. and Koch K. M. (1983). Deposition of an amyloid-like substance as a possible complication of regular dialysis treatment. Contrib. Nephrol., 36, 127

    PubMed  CAS  Google Scholar 

  42. Kanis J. A. (1987). Clodronate - a new perspective in the treatment of neoplastic bone disease. Bone, 8(Suppl. 1), 1

    Article  Google Scholar 

  43. Kanis J. A., Cundy T. and Hamdy N. A. T. (1988). Renal osteodystrophy. Clin. Endocrinol Metab., 2(1), 193

    CAS  Google Scholar 

  44. Kerr D. N. S., Walls J. and Ellis H. (1969). Bone disease in patients undergoing regular haemodialysis. J. Bone Jt Surg., 51 B, 578

    Google Scholar 

  45. Kleinman K. S. and Coburn J. W. (1989). Amyloid syndromes associated with hemodialysis. Kidney Int., 25, 567

    Article  Google Scholar 

  46. Kriegshauser J. S., Swee R. G., McCarthy J. T. and Hauser M. F. (1987). Aluminium toxicity in patients undergoing dialysis: radiographic findings and prediction of bone biopsy results. Radiology, 164, 399

    PubMed  CAS  Google Scholar 

  47. Kurer M. H. J., Baillod R. A. and Madgwick J. C. A. (1991). Musculoskeletal manifestations of amyloidosis: a review of 83 patients on haemodialysis for at least 10 years. J. Bone Jt Surg., 73B, 271

    Google Scholar 

  48. Linke R. P., Nathrath W. B. J. and Eulitz M. (1986). Classification of amyloid syndromes from tissue sections using antibodies against various amyloid fibril proteins: report of 142 cases. Glenner G. G., Osserman E. F., Benditt E. P., Calkins E., Cohen A. S. and Zucker-Franklin D., Amyloidosis New York: Plenum

    Google Scholar 

  49. Llack F. (1991). Renal bone disease. Transplant Proc., 23, 1818

    Google Scholar 

  50. Lopez-Hilker S., Galceran T. and Chan Y. (1986). Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure. J. Clin. Invest, 78, 1097

    Article  PubMed  CAS  Google Scholar 

  51. Malluche H. H., Faugere M.-C., Smith A. J. and Friedler R. M. (1986). Aluminium intoxication of bone in renal failure - fact or fiction? Kidney Int., 29(Suppl. 18), 70

    Google Scholar 

  52. Malluche H. H. and Faugere M.-C. (1986). Atlas of Mineralized Bone Histology. Basel: Karger

    Google Scholar 

  53. Malluche H. H. and Faugere M.-C. (1989). Renal osteodystrophy. N. Engl. J. Med., 321, 317

    Article  PubMed  CAS  Google Scholar 

  54. Malluche H. H., Ritz E. and Lange H. P. (1976). Bone mass in maintenance haemodialysis. Prospective study with sequential biopsies. Eur. J. Clin. Invest., 6, 265

    Article  PubMed  CAS  Google Scholar 

  55. Maloney N. A., Ott S., Alfrey A. C., Miller L. N., Coburg J. W. and Sherrard D. J. (1982). Histologic quantitation of aluminium in iliac bone from patients with renal failure. J. Lab. Clin. Med., 99, 206

    PubMed  CAS  Google Scholar 

  56. McCarthy J. T., Hodgson S. F., Fairbanks V. F. and Moyer T. P. (1991). Clinical and histological features of iron-related bone disease in dialysis patients. Amer. J. Kidney Dis., 17, 551

    CAS  Google Scholar 

  57. McCarthy J. T. and Kumar R. (1990). Renal osteodystrophy. Endocrinol. Metabol. Clin. N. Amer, 19(1), 65

    CAS  Google Scholar 

  58. McCarthy J. T., Milliner D. S., Kurtz S. B., Johnson W. J. and Moyer T. P. (1986). Interpretation of serum aluminium values in dialysis patients. Amer. J. Clin. Pathol, 86, 629

    CAS  Google Scholar 

  59. Meyer J. L. and Thomas W. C. (1986). Aluminium and aluminium complexes. Effect of calcium phosphate precipitation. Kidney Int., 29(Suppl. 18), 20

    Google Scholar 

  60. Norfray J., Calenoff L., DelGreco F. and Krumlovsky F. A. (1975). Renal osteodystrophy in patients on hemodialysis as reflected in the bony pelvis. Amer. J. Roentgenol., 125, 352

    PubMed  CAS  Google Scholar 

  61. Norris K. C., Goodman W. G. and Howard N. (1986). The iliac crest bone biopsy for the diagnosis of aluminium toxicity and a guide to the use of deferoxamine. Semin. Nephrol., 6(Suppl. 1), 27

    PubMed  CAS  Google Scholar 

  62. Parisien M., Charhon S.A., Arlot M., Mainetti E., Chavassieux P., Chapuy M.-C. and Meunier P. J. (1988). Evidence for a toxic effect of aluminium on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease. J. Bone Miner. Res., 3(3), 259

    Article  PubMed  CAS  Google Scholar 

  63. Quarles L. D., Dennis V. W. and Gitelman H. J. (1984). Aluminium deposition in bone: an epiphenomenon of the osteomalacic state. Clin. Res., 32, 522

    Google Scholar 

  64. Revell P. A. (1986). Pathology of Bone Berlin: Springer

    Book  Google Scholar 

  65. Ritz E., Krempien B., Mehls O. and Malluche H. H. (1973). Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int., 4, 116

    Article  PubMed  CAS  Google Scholar 

  66. Russell J. E., Avioli L. V. and Mechanic G. (1975). The nature of the collagen cross-links in bone in the chronic uraemic state. Biochem. J., 145, 119

    PubMed  CAS  Google Scholar 

  67. Russell J. E., Termine J. D. and Avioli L. V. (1973). Abnormal bone mineral maturation in the, chronic uremic state. J. Clin. Invest, 52, 2848

    Article  PubMed  CAS  Google Scholar 

  68. Sherrard D. J. (1991). Aluminium - much ado about something. N. Engl. J. Med., 324, 558

    Article  PubMed  CAS  Google Scholar 

  69. Shusterman N. H., Wasserstein A. G., Morrison G., Audet P., Fallon, M. D. and Kaplan F. (1987). Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis. Amer. J. Med., 82, 1148

    Article  PubMed  CAS  Google Scholar 

  70. Slatoplsky E. (1987). The interaction of parathyroid hormone and aluminium in renal osteodystrophy. Kidney Int., 31, 842

    Article  Google Scholar 

  71. Slatopolsky E. and Coburn J. W. (1990). Renal osteodystrophy. Avioli L. V. and Krane S. M., Metabolic Bone Disease (p. 452). Philadelphia: Saunders

    Google Scholar 

  72. Steiniche T., Mosekilde L., Christensen M. S. and Melsen F. (1989). A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalcuria. Acta Pathol. Microbiol Immunot Scand., 97, 309

    CAS  Google Scholar 

  73. Stewart P. J., Green O. C. and Stern P. H. (1986). Cyclosporine A inhibits calcemic hormone-induced bone resorption in vitro. J. Bone Miner. Res., 1, 285

    Article  PubMed  CAS  Google Scholar 

  74. VandeVyer F. L., Visser W. J., Haese P. C. and DeBroe M. E. (1990). Iron overload and bone disease in chronic dialysis patients. Nephrol. Dial. Transplant., 5, 781

    Article  Google Scholar 

  75. Wills M. R. and Savory J. (1983). Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia. Lancet, 2, 29

    Article  PubMed  CAS  Google Scholar 

References added in proof

  • Coe F. L., Parks J. H. and Asplin J. R. (1992). The pathogenesis and treatment of kidney stones. N. Engl. J. Med., 327, 1141

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1993 R. Bartl and B. Frisch

About this chapter

Cite this chapter

Bartl, R., Frisch, B. (1993). Renal bone disease. In: Biopsy of Bone in Internal Medicine: An Atlas and Sourcebook. Current Histopathology, vol 21. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2222-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-2222-1_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4985-6

  • Online ISBN: 978-94-011-2222-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics